Article info
PDFA difficult case
The borderland of neuromyelitis optica
- Correspondence to Dr Martin Turner, Department of Clinical Neurology, West Wing Level 3, John Radcliffe Hospital, Oxford OX3 9DU, UK; martin.turner{at}clneuro.ox.ac.uk
Citation
The borderland of neuromyelitis optica
Publication history
- First published November 17, 2009.
Online issue publication
April 14, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
BMJ Publishing Group Ltd.
Other content recommended for you
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Relapsing neuromyelitis optica in an adolescent girl
- Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis
- Neuromyelitis optica
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Retinal segmented layers with strong aquaporin-4 expression suffered more injuries in neuromyelitis optica spectrum disorders compared with optic neuritis with aquaporin-4 antibody seronegativity detected by optical coherence tomography
- Neuromyelitis optica: an overview
- Optic neuritis with potential for poor outcome
- Antibodies to myelin oligodendrocyte glycoprotein in idiopathic optic neuritis